Real-world study of Control-IQ in teens with type 1 diabetes who exercise regularly
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study observes how well the Control-IQ insulin pump system works for teenagers with type 1 diabetes who exercise at least twice a week. It aims to see if the technology is safe and effective during regular physical activity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 1 diabetes for more than 12 months.
- You are under 20 years old and have completed puberty.
- You have been using Control-IQ technology for at least 3 months.
- You use the automatic mode at least 70% of the time and wear a continuous glucose monitor at least 70% of the time over the last 2 weeks.
- You exercise regularly, doing at least 2 sessions of 45 minutes or more each week.
- You do not have any uncontrolled thyroid or celiac disease, other chronic illnesses, or mental health conditions that could affect the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a personalized decision-support tool to help people with type 1 diabetes manage their blood sugar during exercise. It involves supervised walking sessions and wearing devices to track your glucose.
This study explores why some teenagers with type 1 diabetes are more active than others. Researchers want to understand the personal, social, and environmental factors that affect exercise habits, which may help improve health outcomes for teens managing diabetes.
This study tests an app called PACTAID that helps adults with type 1 diabetes manage their blood sugar during exercise. You will try three different types of workouts to see how well the app works.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests a new automated insulin delivery system to help people with type 1 diabetes better manage their blood sugar. It aims to see if the system improves glucose control safely.
This study tests a new insulin pump system (Tandem Mobi) with a continuous glucose monitor for young athletes with type 1 diabetes. It looks at how well the system works and how it feels to use during sports.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.